These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 11414092)
21. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mäkinen K; Manninen H; Hedman M; Matsi P; Mussalo H; Alhava E; Ylä-Herttuala S Mol Ther; 2002 Jul; 6(1):127-33. PubMed ID: 12095313 [TBL] [Abstract][Full Text] [Related]
22. Hypoxic induction of vascular endothelial growth factor is markedly decreased in diabetic individuals who do not develop retinopathy. Marsh S; Nakhoul FM; Skorecki K; Rubin A; Miller BP; Leibu R; Levy NS; Levy AP Diabetes Care; 2000 Sep; 23(9):1375-80. PubMed ID: 10977036 [TBL] [Abstract][Full Text] [Related]
23. Patients with diabetes and critical limb ischemia have a high peripheral vascular resistance. Wahlberg E; Jörneskog G Ann Vasc Surg; 1997 May; 11(3):224-9. PubMed ID: 9140595 [TBL] [Abstract][Full Text] [Related]
24. Reversal of angiogenic growth factor upregulation by revascularization of lower limb ischemia. Porcu P; Emanueli C; Kapatsoris M; Chao J; Chao L; Madeddu P Circulation; 2002 Jan; 105(1):67-72. PubMed ID: 11772878 [TBL] [Abstract][Full Text] [Related]
25. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Rissanen TT; Vajanto I; Hiltunen MO; Rutanen J; Kettunen MI; Niemi M; Leppänen P; Turunen MP; Markkanen JE; Arve K; Alhava E; Kauppinen RA; Ylä-Herttuala S Am J Pathol; 2002 Apr; 160(4):1393-403. PubMed ID: 11943724 [TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Mathews MK; Merges C; McLeod DS; Lutty GA Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2729-41. PubMed ID: 9418725 [TBL] [Abstract][Full Text] [Related]
27. Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial. Rajagopalan S; Mohler E; Lederman RJ; Saucedo J; Mendelsohn FO; Olin J; Blebea J; Goldman C; Trachtenberg JD; Pressler M; Rasmussen H; Annex BH; Hirsch AT; Am Heart J; 2003 Jun; 145(6):1114-8. PubMed ID: 12796772 [TBL] [Abstract][Full Text] [Related]
28. Risk factors for development of critical limb ischemia -- a survey of diabetic vs. nondiabetic population. Bosevski M; Meskovska S; Tosev S; Peovska I; Asikov I; Georgievska-Ismail LJ Prilozi; 2006 Dec; 27(2):89-96. PubMed ID: 17211294 [TBL] [Abstract][Full Text] [Related]
39. New options for untreatable coronary artery disease: angiogenesis and laser revascularization. Mukherjee D; Ellis SG Cleve Clin J Med; 2000 Aug; 67(8):577-83. PubMed ID: 10946453 [TBL] [Abstract][Full Text] [Related]
40. Role of fenofibrate in restoring angiogenesis in diabetic and control hind limb ischemic rats. Salehi E; Khazaei M; Rashidi B Gen Physiol Biophys; 2012 Sep; 31(3):255-60. PubMed ID: 23047938 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]